Once again the FDA has updated the label on the drug Tysabri. Tysabri, manufactured by Biogen Idec, Inc. and Elan Corp. Plc., is used by pateints with multiple sclerosis. Signs of liver damage occurred in some patients taking the drug. Liver problems may lead to death or the need for a transplant.
Comments are closed.